Bone Medical Limited Stock Australian S.E.
Equities
AU000000BNE6
Pharmaceuticals
End-of-day quote
Other stock markets
|
||
- AUD | - |
|
Sales 2024 * | 800M 540M | Sales 2025 * | 30.5B 20.58B | Capitalization | 615M 415M |
---|---|---|---|---|---|
Net income 2024 * | -11.7B -7.9B | Net income 2025 * | 9.3B 6.28B | EV / Sales 2024 * | -11.2 x |
Net cash position 2024 * | 9.6B 6.48B | Net cash position 2025 * | 2.3B 1.55B | EV / Sales 2025 * | -0.06 x |
P/E ratio 2024 * |
-34
x | P/E ratio 2025 * |
34
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 85.28% |
Managers | Title | Age | Since |
---|---|---|---|
Howie McKibbon
CEO | Chief Executive Officer | - | 19-04-30 |
Vincent Ippolito
CHM | Chairman | 65 | 19-05-19 |
Chief Tech/Sci/R&D Officer | 68 | 21-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Stewart Washer
BRD | Director/Board Member | 54 | 19-02-20 |
Henry Bosch
BRD | Director/Board Member | - | 16-06-30 |
Vincent Ippolito
CHM | Chairman | 65 | 19-05-19 |
1st Jan change | Capi. | |
---|---|---|
+22.78% | 9.56B | |
-21.31% | 4.48B | |
+30.09% | 4.85B | |
+24.78% | 3.9B | |
-2.11% | 1.99B | |
+11.03% | 2.01B | |
-36.28% | 1.89B | |
-43.19% | 1.77B | |
-0.50% | 1.64B |